DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1Zhe Hong, Haojie Huang, R. Jeffrey Karnes et al.|Molecular Cell|2020Cited by 49
A phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707) (1308)Matthew S. Block, Svetomir N. Markovic, Carrie Langstraat et al.|Gynecologic Oncology|2023Cited by 1